Literature DB >> 9651561

Serum 25-hydroxyvitamin D levels and bone mineral density in 16-20 years-old girls: lack of association.

J O Kristinsson1, O Valdimarsson, G Sigurdsson, L Franzson, I Olafsson, L Steingrimsdottir.   

Abstract

OBJECTIVE: Hypovitaminosis D has been shown to be associated with low bone mineral density in middle-aged and elderly women. The aim of this study was to evaluate whether such an association might exist in adolescent and young adult girls, approaching peak bone mass.
DESIGN: Cross-sectional study carried out in late winter.
SETTING: Reykjavik area at latitude 64 degrees N.
SUBJECTS: Two-hundred and fifty-nine Icelandic Caucasian girls, aged 16, 18 and 20 years, randomly selected from the registry of Reykjavik. MAIN OUTCOME MEASURES: Bone mineral density in lumbar spine, hip, distal forearm and total skeleton was measured with dual-energy X-ray absorptiometry (DEXA) and compared with 25-hydroxyvitamin D levels [25 (OH)D] in serum, measured by radioimmunoassay. Calcium and vitamin-D intake were also assessed by a questionnaire.
RESULTS: 18.5% of the girls were below 25 nmol L-1 in serum 25 (OH)D which has been recognized as the lower normal limit for adults. No significant association was found between 25 (OH)D levels and bone mineral density.
CONCLUSIONS: Normal calcium and phosphate concentrations in plasma and normal bone mineral density are maintained in adolescent and young adult girls at lower 25 (OH)D levels than published 'normal' levels for middle-aged and elderly.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9651561     DOI: 10.1046/j.1365-2796.1998.00302.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  12 in total

1.  Determinants of bone microarchitecture and mechanical properties in obese men.

Authors:  Miriam A Bredella; Eleanor Lin; Anu V Gerweck; Melissa G Landa; Bijoy J Thomas; Martin Torriani; Mary L Bouxsein; Karen K Miller
Journal:  J Clin Endocrinol Metab       Date:  2012-08-29       Impact factor: 5.958

2.  Determinants of bone mineral density in obese premenopausal women.

Authors:  Miriam A Bredella; Martin Torriani; Reza Hosseini Ghomi; Bijoy J Thomas; Danielle J Brick; Anu V Gerweck; Lindsey M Harrington; Anne Breggia; Clifford J Rosen; Karen K Miller
Journal:  Bone       Date:  2010-12-30       Impact factor: 4.398

3.  Efficacy of optimization of vitamin D in preventing osteoporosis and osteoporotic fractures: A systematic review.

Authors:  Kazutoshi Nakamura; Masayuki Iki
Journal:  Environ Health Prev Med       Date:  2006-07       Impact factor: 3.674

Review 4.  Perspectives on osteoporosis in pediatric inflammatory bowel disease.

Authors:  Manisha Harpavat; David J Keljo
Journal:  Curr Gastroenterol Rep       Date:  2003-06

5.  Vitamin D status and its relationship to body fat, final height, and peak bone mass in young women.

Authors:  Richard Kremer; Patricia P Campbell; Timothy Reinhardt; Vicente Gilsanz
Journal:  J Clin Endocrinol Metab       Date:  2008-11-04       Impact factor: 5.958

6.  Vitamin-D nutrition and bone mass in adolescent black girls.

Authors:  Sonia A Talwar; Jane Swedler; James Yeh; Simcha Pollack; John F Aloia
Journal:  J Natl Med Assoc       Date:  2007-06       Impact factor: 1.798

7.  Bone mineral density in children with familial Mediterranean fever.

Authors:  Ali Duzova; Fatih Ozaltin; Alev Ozon; Nesrin Besbas; Rezan Topaloglu; S Ozen; A Bakkaloglu
Journal:  Clin Rheumatol       Date:  2004-04-17       Impact factor: 2.980

8.  The genetics of osteoporosis: vitamin D receptor gene polymorphisms and circulating osteocalcin in healthy Irish adults.

Authors:  D Sheehan; T Bennett; K Cashman
Journal:  Ir J Med Sci       Date:  2001 Jan-Mar       Impact factor: 2.089

9.  Vitamin D: An overview of vitamin D status and intake in Europe.

Authors:  A Spiro; J L Buttriss
Journal:  Nutr Bull       Date:  2014-12

10.  Determinants of vitamin D status in young adults: influence of lifestyle, sociodemographic and anthropometric factors.

Authors:  Rune Tønnesen; Peter Hambak Hovind; Lars Thorbjørn Jensen; Peter Schwarz
Journal:  BMC Public Health       Date:  2016-05-11       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.